215 related articles for article (PubMed ID: 17909835)
21. Soluble vascular endothelial growth factor receptor-3 suppresses allosensitization and promotes corneal allograft survival.
Emami-Naeini P; Dohlman TH; Omoto M; Hattori T; Chen Y; Lee HS; Chauhan SK; Dana R
Graefes Arch Clin Exp Ophthalmol; 2014 Nov; 252(11):1755-62. PubMed ID: 25091513
[TBL] [Abstract][Full Text] [Related]
22. Combined blockade of VEGFR-3 and VLA-1 markedly promotes high-risk corneal transplant survival.
Zhang H; Grimaldo S; Yuen D; Chen L
Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6529-35. PubMed ID: 21715348
[TBL] [Abstract][Full Text] [Related]
23. Differential distribution of blood and lymphatic vessels in the murine cornea.
Ecoiffier T; Yuen D; Chen L
Invest Ophthalmol Vis Sci; 2010 May; 51(5):2436-40. PubMed ID: 20019372
[TBL] [Abstract][Full Text] [Related]
24. Evidence of corneal lymphangiogenesis in dry eye disease: a potential link to adaptive immunity?
Goyal S; Chauhan SK; El Annan J; Nallasamy N; Zhang Q; Dana R
Arch Ophthalmol; 2010 Jul; 128(7):819-24. PubMed ID: 20625040
[TBL] [Abstract][Full Text] [Related]
25. Photodynamic Therapy Leads to Time-Dependent Regression of Pathologic Corneal (Lymph) Angiogenesis and Promotes High-Risk Corneal Allograft Survival.
Hou Y; Le VNH; Clahsen T; Schneider AC; Bock F; Cursiefen C
Invest Ophthalmol Vis Sci; 2017 Nov; 58(13):5862-5869. PubMed ID: 29145577
[TBL] [Abstract][Full Text] [Related]
26. Transient postoperative vascular endothelial growth factor (VEGF)-neutralisation improves graft survival in corneas with partly regressed inflammatory neovascularisation.
Bachmann BO; Luetjen-Drecoll E; Bock F; Wiegand SJ; Hos D; Dana R; Kruse FE; Cursiefen C
Br J Ophthalmol; 2009 Aug; 93(8):1075-80. PubMed ID: 19224901
[TBL] [Abstract][Full Text] [Related]
27. Tumour necrosis factor superfamily member 15 (Tnfsf15) facilitates lymphangiogenesis via up-regulation of Vegfr3 gene expression in lymphatic endothelial cells.
Qin TT; Xu GC; Qi JW; Yang GL; Zhang K; Liu HL; Xu LX; Xiang R; Xiao G; Cao H; Wei Y; Zhang QZ; Li LY
J Pathol; 2015 Nov; 237(3):307-18. PubMed ID: 26096340
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival.
Cursiefen C; Cao J; Chen L; Liu Y; Maruyama K; Jackson D; Kruse FE; Wiegand SJ; Dana MR; Streilein JW
Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2666-73. PubMed ID: 15277490
[TBL] [Abstract][Full Text] [Related]
29. Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin.
Cursiefen C; Schlötzer-Schrehardt U; Küchle M; Sorokin L; Breiteneder-Geleff S; Alitalo K; Jackson D
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2127-35. PubMed ID: 12091407
[TBL] [Abstract][Full Text] [Related]
30. Suppression of inflammatory corneal lymphangiogenesis by application of topical corticosteroids.
Hos D; Saban DR; Bock F; Regenfuss B; Onderka J; Masli S; Cursiefen C
Arch Ophthalmol; 2011 Apr; 129(4):445-52. PubMed ID: 21482870
[TBL] [Abstract][Full Text] [Related]
31. Serum eyedrops antagonize the anti(lymph)angiogenic effects of bevacizumab in vitro and in vivo.
Hos D; Koch KR; Bucher F; Bock F; Cursiefen C; Heindl LM
Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6133-42. PubMed ID: 23970469
[TBL] [Abstract][Full Text] [Related]
32. Cellular-level characterization of lymph vessels in live, unlabeled corneas by in vivo confocal microscopy.
Peebo BB; Fagerholm P; Traneus-Röckert C; Lagali N
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):830-5. PubMed ID: 19797212
[TBL] [Abstract][Full Text] [Related]
33. Netrin-4 Mediates Corneal Hemangiogenesis but Not Lymphangiogenesis in the Mouse-Model of Suture-Induced Neovascularization.
Maier AB; Klein S; Kociok N; Riechardt AI; Gundlach E; Reichhart N; Strauß O; Joussen AM
Invest Ophthalmol Vis Sci; 2017 Mar; 58(3):1387-1396. PubMed ID: 28253401
[TBL] [Abstract][Full Text] [Related]
34. Blockade of insulin receptor substrate-1 inhibits corneal lymphangiogenesis.
Hos D; Regenfuss B; Bock F; Onderka J; Cursiefen C
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5778-85. PubMed ID: 21666240
[TBL] [Abstract][Full Text] [Related]
35. Age-related changes in murine limbal lymphatic vessels and corneal lymphangiogenesis.
Hos D; Bachmann B; Bock F; Onderka J; Cursiefen C
Exp Eye Res; 2008 Nov; 87(5):427-32. PubMed ID: 18755186
[TBL] [Abstract][Full Text] [Related]
36. Spontaneous corneal hem- and lymphangiogenesis in mice with destrin-mutation depend on VEGFR3 signaling.
Cursiefen C; Ikeda S; Nishina PM; Smith RS; Ikeda A; Jackson D; Mo JS; Chen L; Dana MR; Pytowski B; Kruse FE; Streilein JW
Am J Pathol; 2005 May; 166(5):1367-77. PubMed ID: 15855638
[TBL] [Abstract][Full Text] [Related]
37. The maintenance of lymphatic vessels in the cornea is dependent on the presence of macrophages.
Maruyama K; Nakazawa T; Cursiefen C; Maruyama Y; Van Rooijen N; D'Amore PA; Kinoshita S
Invest Ophthalmol Vis Sci; 2012 May; 53(6):3145-53. PubMed ID: 22511631
[TBL] [Abstract][Full Text] [Related]
38. Soluble vascular endothelial growth factor receptor 3 is essential for corneal alymphaticity.
Singh N; Tiem M; Watkins R; Cho YK; Wang Y; Olsen T; Uehara H; Mamalis C; Luo L; Oakey Z; Ambati BK
Blood; 2013 May; 121(20):4242-9. PubMed ID: 23476047
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of lymphangiogenesis in vitro and in vivo by the multikinase inhibitor nintedanib.
Lin T; Gong L
Drug Des Devel Ther; 2017; 11():1147-1158. PubMed ID: 28435226
[TBL] [Abstract][Full Text] [Related]
40. Fine Needle-Diathermy Regresses Pathological Corneal (Lymph)Angiogenesis and Promotes High-Risk Corneal Transplant Survival.
Le VNH; Schneider AC; Scholz R; Bock F; Cursiefen C
Sci Rep; 2018 Apr; 8(1):5707. PubMed ID: 29632336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
